CYP2C9 c.1149+1981T>A

Variant ID: 10-96743108-T-A

NM_000771.3(CYP2C9):c.1149+1981T>A

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain.

Scientific Reports
Cullell, Natalia N; Carrera, Caty C; Muiño, Elena E; Torres-Aguila, Nuria-Paz NP; Cárcel-Márquez, Jara J; González-Sánchez, Jonathan J; Gallego-Fabrega, Cristina C; Molina, Jessica J; Besora, Sarah S; Sotoca, Javier J; Buongiorno, Maria-Teresa MT; Jiménez-Conde, Jordi J; Giralt-Steinhauer, Eva E; de Torres-Chacón, Reyes R; Montaner, Joan J; Mancha, Fernando F; Cabezas, Juan A JA; Martí-Fàbregas, Joan J; Prats-Sánchez, Luis L; Camps-Renom, Pol P; Purroy, Francisco F; Cambray, Serafi S; Freijo, María Del Mar MDM; Vives-Bauzá, Cristòfol C; Tur, Silvia S; Font, Maria-Àngels MÀ; López-Cancio, Elena E; Hernandez-Perez, Maria M; Obach, Victor V; Calleja, Ana A; Arenillas, Juan J; Rodríguez-Yáñez, Manuel M; Castillo, José J; Sobrino, Tomas T; Fernández-Cádenas, Israel I; Krupinski, Jerzy J
Publication Date: 2020-02-18

Variant appearance in text: rs9332214
PubMed Link: 32071341
Variant Present in the following documents:
  • Main text
  • 41598_2020_Article_59641.pdf
View BVdb publication page



The presence of two reduced function variants in CYP2C9 influences the acute response to glipizide.

Diabetic Medicine : A Journal Of The British Diabetic Association
Chen, L L; Li, J H JH; Kaur, V V; Muhammad, A A; Fernandez, M M; Hudson, M S MS; Goldfine, A B AB; Florez, J C JC
Publication Date: 2020-12

Variant appearance in text: rs9332214
PubMed Link: 31709648
Variant Present in the following documents:
  • Main text
View BVdb publication page



Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs9332214
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans.

Genome Medicine
Gottlieb, Assaf A; Daneshjou, Roxana R; DeGorter, Marianne M; Bourgeois, Stephane S; Svensson, Peter J PJ; Wadelius, Mia M; Deloukas, Panos P; Montgomery, Stephen B SB; Altman, Russ B RB
Publication Date: 2017-11-24

Variant appearance in text: rs9332214
PubMed Link: 29178968
Variant Present in the following documents:
  • Main text
  • 13073_2017_Article_495.pdf
View BVdb publication page



An integrative method for scoring candidate genes from association studies: application to warfarin dosing.

Bmc Bioinformatics
Tatonetti, Nicholas P NP; Dudley, Joel T JT; Sagreiya, Hersh H; Butte, Atul J AJ; Altman, Russ B RB
Publication Date: 2010-10-28

Variant appearance in text: rs9332214
PubMed Link: 21044367
Variant Present in the following documents:
  • Main text
  • 1471-2105-11-S9-S9.pdf
View BVdb publication page



Association of warfarin dose with genes involved in its action and metabolism.

Human Genetics
Wadelius, Mia M; Chen, Leslie Y LY; Eriksson, Niclas N; Bumpstead, Suzannah S; Ghori, Jilur J; Wadelius, Claes C; Bentley, David D; McGinnis, Ralph R; Deloukas, Panos P
Publication Date: 2007-03

Variant appearance in text: rs9332214
PubMed Link: 17048007
Variant Present in the following documents:
  • Main text
  • 439_2006_Article_260.pdf
View BVdb publication page